Breast Cancer News

SAN ANTONIO — Use of fertility preservation or assisted reproductive technology did not increase recurrence risk among patients with hormone receptor-positive breast cancer who paused endocrine therapy to become pregnant, results showed.

Alana L. Welm, PhD, will receive the AACR Outstanding Investigator Award for Breast Cancer Research during this year’s San Antonio Breast Cancer Symposium.

Pembrolizumab plus olaparib did not improve outcomes among patients with locally recurrent inoperable or metastatic triple-negative breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

SAN ANTONIO — The addition of atezolizumab to adjuvant chemotherapy “is very unlikely” to improve DFS for women with stage II or stage III triple-negative breast cancer, according to data presented at San Antonio Breast Cancer Symposium.

SAN ANTONIO — An immunotherapy-chemotherapy combination conferred benefit for certain patients with high-risk breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

The addition of tucatinib to ado-trastuzumab emtansine significantly improved PFS among patients with unresectable locally advanced or metastatic HER2-positive breast cancer, according to study findings.

SAN ANTONIO — Treatment de-escalation may be possible for patients with breast cancer who respond well to neoadjuvant chemotherapy, according to randomized phase 3 study results presented at San Antonio Breast Cancer Symposium.

Kornelia Polyak, MD, PhD, FAACR, will receive this year’s AACR Distinguished Lectureship in Breast Cancer Research at San Antonio Breast Cancer Symposium.

Women who regularly attended their mammogram screenings before a breast cancer diagnosis had up to a 72% reduced risk for death compared with those who attended none, according to a recent study.

For individuals diagnosed with cancer, guideline-concordant exercise reduced all-cause mortality by 25% compared with patients with cancer who did not exercise, study results published in Journal of Clinical Oncology showed.